How does TSVT compare to its industry peers - Best Dividend Picks For 2025 - jammulinksnews.com
22 hours ago • Google News
2Seventy Bio Inc (TSVT)
US$ 4.99-0.2%
Price Chart
Key Statistics
Market Cap
$ 266.14M
P/E Ratio
0.00
Revenue (TTM)
$ 48.37M
Volume
344.61K
52W High
$ 5.30
52W Low
$ 2.29
Dividend Yield
0.00%
Beta
1.05
Technicals
50-Day MA
4.9738
200-Day MA
4.0477
52 Week High
5.3
52 Week Low
2.29
About TSVT
2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States.
Employees
65
Headquarters
Cambridge, MA
CEO
Mr. William D. Baird III, M.B.A.
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg